Medtronic plc (MDT)
Healthcare · Medical - Devices · Data as of 2026-09-01
Bottom line
MDT is trading at a discount to its history, near its historical support zone, and recent volume shows no clear direction. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
MDT trades at 23× earnings, below its own 5-year average of 28× and below similar healthcare companies we track (29×, 52 peers). Historically this has been on the cheaper side for the stock. Its free-cash-flow yield is about 5.2%. Its current multiple sits around the 11th percentile of its own last five years — toward the low end of its own range. Its fundamentals scored 8 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — Near its historical support zone (Green)
At $92.04, the stock is close to the lower end of its recent range. Over the past year MDT has traded between $73.31 and $106.33; its historical support zone sits near $89.76 and resistance near $106.33. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $73.31–$106.33 · 50-day average $85.97 · 200-day average $89.76
Money flow — No clear direction (Yellow)
Buying and selling volume in MDT have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 1.4× volume on down days over the last 30 sessions.
About the company
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software.
一句话结论
MDT 相对自身历史处于折价水平，接近其历史支撑区，近期成交量没有明确方向。从历史来看，这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
MDT 目前的市盈率为 23×，低于其自身 5 年平均的 28×，并且低于我们追踪的同类Healthcare公司（29×，52 家）。从历史来看，这属于该股较便宜的一侧。其自由现金流收益率约为 5.2%。它当前的估值倍数大约位于自身过去五年分布的第 11 百分位——处于自身区间的偏低位置。在一套标准的逐年基本面核对清单上，它 9 项中通过了 8 项——上一财年多数底层趋势在改善。
价格区间 — 接近其历史支撑区
目前价格为 $92.04，接近其近期区间的下沿。过去一年 MDT 的价格在 $73.31 到 $106.33 之间波动；其历史支撑区在 $89.76 附近，阻力区在 $106.33 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 方向不明确
MDT 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 1.4×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.